Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Neurobiol Aging. 2017 Feb 16;54:1–9. doi: 10.1016/j.neurobiolaging.2017.02.005

Table 1.

Demographics for all participants with MCI who had longitudinal data

Converted to AD Other participants p-value
Participants (female) 17 (9) 99 (42) 1.0000
Age at baseline [years] 72.05 (1.97) 70.86 (0.69) 1.0000
Time between scans [years] 2.04 (0.02) 2.01 (0.01) 1.0000
Education [years] 16.94 (0.57) 16.44 (0.27) 1.0000
APOE ε4 [# alleles] 1.06 (0.18) 0.45 (0.06) 0.1060*
MMSE at baseline [−] 27.06 (0.50) 28.35 (0.16) 0.4672*
MMSE difference [−] −3.65 (0.62) −0.28 (0.20) 0.0010
ADAS13 at baseline [−] 21.94 (1.37) 12.11 (0.54) <0.0001
ADAS13 difference [−] 8.06 (1.43) −0.20 (0.43) 0.0005
CDR-SB at baseline [−] 2.50 (0.20) 1.23 (0.11) <0.0001
CDR-SB difference [−] 2.68 (0.33) −0.04 (0.12) <0.0001
Global thickness diff. [mm/year] −0.033 (0.008) −0.009 (0.002) 0.1455*
AD regional thick. diff. [mm/year] −0.041 (0.009) −0.013 (0.002) 0.1656*
WM Lesion vol. diff. [mm3/year] 1199 (291) 413 (57) 0.3522*
Hippocampal vol. diff. [mm3/year] −264 (31) −58 (10) <0.0001
Ventricular vol. diff. [mm3/year] 3949 (496) 1439 (140) 0.0024
Total WM vol. diff. [mm3/year] −5922 (979) −3331 (346) 0.4487*
AVF (baseline) −0.594 (0.230) −0.008 (0.106) 0.6326*
AVF (difference) −0.381 (0.053) −0.146 (0.014) 0.0089
NDF (baseline) 0.286 (0.248) 0.872 (0.069) 0.7300*
NDF (difference) −0.434 (0.115) −0.129 (0.028) 0.3915*

Standard errors of the mean are shown in parentheses, except for the first row where number of female participants is displayed. χ2 and two-tailed t tests were used to obtain the p-values. Difference defined as value at follow-up minus value at baseline. All tests were corrected using a Bonferroni correction for 21 comparisons (bolded represents significant when corrected, while * represents significant when uncorrected). An average negative AVF value at baseline indicates that the average individual of the replication sample had slightly higher white matter hyperintensities and ventricular volume when compared to the distribution of the original sample. An average positive NDF value at baseline in turn means that individuals of the replication sample had slightly higher hippocampal volume and cortical thickness when compared to the distribution of the original sample. The scale is largely arbitrary and is generally useful to compare across individuals. (MMSE: Mini-Mental State Exam; ADAS-Cog 13: Alzheimer’s Disease Assessment Scale; CDR-SB: Clinical Dementia Rating – Sum of Boxes; MCI: mild cognitive impairment; AVF: age- and vascular-related factor; NDF: neurodegenerative factor)